FDA Recalls Launch Sequence Euphoria Capsules for Undeclared Tadalafil
Launch Sequence Euphoria Capsules have been recalled because the product contains undeclared tadalafil, an unapproved active ingredient. The capsules were distributed nationwide in the USA and Canada.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I recall of an unapproved drug containing an undeclared active pharmaceutical ingredient. While no illnesses or injuries have been reported, the product poses a significant regulatory and safety concern.
Plain-English summary
Launch Sequence Euphoria Capsules, marketed in 10-count tins by Loud Muscle Science, have been recalled by the FDA. The product was found to contain undeclared tadalafil, an active ingredient used in FDA-approved medications for male sexual enhancement. Because the product lacks an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA), it is classified as an unapproved drug.
The recalled product includes lot #2022104 with an expiration date of April 2025. Approximately 1,000 units of 10-count tins were distributed nationwide in the USA and Canada.
Consumers who have purchased this product should discontinue use immediately. Those with questions or health concerns should contact their healthcare provider.
The recalled product
- Product
- Launch Sequence Euphoria Capsules, 10- count tins, ASIN B08ZJX4V9J, UPC Code 661020846864.
- Manufacturer
- Loud Muscle Science
- Category
- Drug — Supplement
- Hazard
- unapproved-drug
- undeclared-tadalafil
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 2022104
- Exp. Date 04/2025
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27